Home › Trial NCT05262010
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 18-45 Years
- Trial IDNCT05262010
- StatusActive Not Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorNational Vaccine and Serum Institute, China
- Enrollment13500
- Start date2022-06-04
- ConditionsHPV InfectioN · HPV-Related Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.